KRAS and neoplasm: The present study uncovered a rare co-occurrence of KRAS (G13D) and BRAF (V600E) alterations in CRC, highlighting tumor heterogeneity and challenging the assumption that these mutations are mutually exclusive within the studied ethnicity.